Sanctuary Advisors, LLC Immunity Bio, Inc. Transaction History
Sanctuary Advisors, LLC
- $15.8 Trillion
- Q4 2024
A detailed history of Sanctuary Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 30,184 shares of IBRX stock, worth $96,286. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,184
Previous 29,184
3.43%
Holding current value
$96,286
Previous $149 Million
29.63%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IBRX
# of Institutions
208Shares Held
70.1MCall Options Held
1.64MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$53.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$36.4 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$27.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$12.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$7.17 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.28B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...